Back

Effects of Mavacamten use in a patient with hypertrophic obstructive cardiomyopathy and extremely high resting left ventricular outflow tract gradient

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: from obstruction to innovation Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Elizabeth Wang

Tan Tock Seng Hospital, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Integrated surgical management of obstructive hypertrophic cardiomyopathy and heart failure: septal myectomy with mitral valve repair
Doctor C. Angelescu (Bucharest, RO)
Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy at the diagnostic threshold of Gaucher disease
Doctor M. Malek-Elikowska (Poznan, PL)
Slides Video
Presentation thumbnail
When calcification meets motion: mitral annular calcification and systolic anterior motion of the mitral valve driving heart failure in HOCM
Doctor C. Angelescu (Bucharest, RO)
Slides Video
Presentation thumbnail
FLCN-related HCM: A patient with a potential novel truncating variant presenting with septal and apical LV hypertrophy and high-risk for malignant ventricular arrhythmias
Doctor R. Montalvao (Lisboa, PT)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: from obstruction to innovation
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Hypertrophic cardiomyopathy: from obstruction to innovation
thumbnail
Congress Session
HCM Summit: navigating patient cases
thumbnail
Congress Session
Cardiomyopathies cases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources